IC
GMAB icon

IEQ Capital’s Genmab GMAB Stock Holding History

IEQ Capital’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$449K Sell
16,747
-374
-2% -$11.2K ﹤0.01% 1356
2025
Q4 		$527K Buy
17,121
+1,218
+8% +$38K ﹤0.01% 1307
2025
Q3 		$488K Buy
+15,903
New +$388K ﹤0.01% 1302

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

IEQ Capital's GMAB Position: Q1 2026 in Review

IEQ Capital reduced its Genmab (GMAB) stake by 2.2% in Q1 2026, selling an estimated $11.2K and leaving 16,747 shares worth $449K. The position accounts for ﹤0.01% of the portfolio, ranked #1356.

IEQ Capital first reported a position in GMAB in Q3 2025 and has held it in 3 quarters since. The position peaked at $527K in Q4 2025. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • IEQ Capital held 16,747 shares of Genmab worth $449K as of Q1 2026.
  • IEQ Capital sold 374 Genmab shares in Q1 2026, an estimated $11.2K.
  • Genmab made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1356 holding.
  • IEQ Capital first reported a position in Genmab in Q3 2025 and has held it in 3 quarters since.
  • IEQ Capital's Genmab position peaked at $527K in Q4 2025.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.